Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds
- PMID: 23071201
- DOI: 10.1542/peds.2012-1516
Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds
Abstract
Objective: Previous surveys on hypothesized sexual activity changes after human papillomavirus (HPV) vaccination may be subject to self-response biases. To date, no studies measured clinical markers of sexual activity after HPV vaccination. This study evaluated sexual activity-related clinical outcomes after adolescent vaccination.
Methods: We conducted a retrospective cohort study utilizing longitudinal electronic data from a large managed care organization. Girls enrolled in the managed care organization, aged 11 through 12 years between July 2006 and December 2007, were classified by adolescent vaccine (HPV; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis, adsorbed; quadrivalent meningococcal conjugate) receipt. Outcomes (pregnancy/sexually transmitted infection testing or diagnosis; contraceptive counseling) were assessed through December 31, 2010, providing up to 3 years of follow-up. Incidence rate ratios comparing vaccination categories were estimated with multivariate Poisson regression, adjusting for health care-seeking behavior and demographic characteristics.
Results: The cohort included 1398 girls (493 HPV vaccine-exposed; 905 HPV vaccine-unexposed). Risk of the composite outcome (any pregnancy/sexually transmitted infection testing or diagnosis or contraceptive counseling) was not significantly elevated in HPV vaccine-exposed girls relative to HPV vaccine-unexposed girls (adjusted incidence rate ratio: 1.29, 95% confidence interval [CI]: 0.92 to 1.80; incidence rate difference: 1.6/100 person-years; 95% CI: -0.03 to 3.24). Incidence rate difference for Chlamydia infection (0.06/100 person-years [95% CI: -0.30 to 0.18]) and pregnancy diagnoses (0.07/100 person-years [95% CI: -0.20 to 0.35]), indicating little clinically meaningful absolute risk differences.
Conclusions: HPV vaccination in the recommended ages was not associated with increased sexual activity-related outcome rates.
Similar articles
-
Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study.CMAJ. 2015 Feb 3;187(2):E74-E81. doi: 10.1503/cmaj.140900. Epub 2014 Dec 8. CMAJ. 2015. PMID: 25487660 Free PMC article.
-
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial.Pediatr Infect Dis J. 2011 Dec;30(12):e225-34. doi: 10.1097/INF.0b013e31822d28df. Pediatr Infect Dis J. 2011. PMID: 21817954 Clinical Trial.
-
Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians.Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2325-32. doi: 10.1158/1055-9965.EPI-09-0184. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19661092
-
Human Papillomavirus Vaccination and Sexual Disinhibition in Females: A Systematic Review.Am J Prev Med. 2016 Sep;51(3):373-83. doi: 10.1016/j.amepre.2016.03.015. Epub 2016 Apr 26. Am J Prev Med. 2016. PMID: 27130864 Review.
-
Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research.Hum Vaccin Immunother. 2016 Jun 2;12(6):1435-50. doi: 10.1080/21645515.2016.1141158. Epub 2016 Feb 10. Hum Vaccin Immunother. 2016. PMID: 26864126 Free PMC article. Review.
Cited by
-
Human papillomavirus vaccine uptake among adolescent survivors of hematopoietic stem cell transplant.J Cancer Surviv. 2024 Nov 18. doi: 10.1007/s11764-024-01709-w. Online ahead of print. J Cancer Surviv. 2024. PMID: 39556189
-
Human Papillomavirus (HPV) Infection and Risk Behavior in Vaccinated and Non-Vaccinated Paraguayan Young Women.Pathogens. 2024 Feb 27;13(3):209. doi: 10.3390/pathogens13030209. Pathogens. 2024. PMID: 38535552 Free PMC article.
-
Analysis of Parents' Attitudes and Knowledge toward Immunization and How These Factors Influence Their Decisions to Vaccinate Their Children against Human Papilloma Virus (HPV).Medicina (Kaunas). 2023 Sep 30;59(10):1755. doi: 10.3390/medicina59101755. Medicina (Kaunas). 2023. PMID: 37893473 Free PMC article.
-
Attitudes towards HPV Vaccination Policy Strategies to Improve Adolescent Vaccination Coverage among Pediatric Providers in New York State.Vaccines (Basel). 2023 Aug 12;11(8):1359. doi: 10.3390/vaccines11081359. Vaccines (Basel). 2023. PMID: 37631926 Free PMC article.
-
Patient-Provider Health Communication Strategies: Enhancing HPV Vaccine Uptake among Adolescents of Color.Healthcare (Basel). 2023 Jun 10;11(12):1702. doi: 10.3390/healthcare11121702. Healthcare (Basel). 2023. PMID: 37372820 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
